James S. Ketter

Array ( [id] => 3729803 [patent_doc_number] => 05665550 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-09 [patent_title] => 'Genes and genetic elements associated with sensitivity to chemotherapeutic drugs' [patent_app_type] => 1 [patent_app_number] => 8/480552 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 40 [patent_no_of_words] => 10080 [patent_no_of_claims] => 93 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/665/05665550.pdf [firstpage_image] =>[orig_patent_app_number] => 480552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3664843 [patent_doc_number] => 05599679 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-04 [patent_title] => 'Amino procollagen 1(I) peptides' [patent_app_type] => 1 [patent_app_number] => 8/479233 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7206 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/599/05599679.pdf [firstpage_image] =>[orig_patent_app_number] => 479233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3646826 [patent_doc_number] => 05639622 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-17 [patent_title] => 'Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof' [patent_app_type] => 1 [patent_app_number] => 8/478860 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4018 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/639/05639622.pdf [firstpage_image] =>[orig_patent_app_number] => 478860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3997867 [patent_doc_number] => 05858657 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Methods for producing members of specific binding pairs' [patent_app_type] => 1 [patent_app_number] => 8/480006 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 24 [patent_no_of_words] => 31355 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858657.pdf [firstpage_image] =>[orig_patent_app_number] => 480006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1449651 [patent_doc_number] => 06455275 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-24 [patent_title] => 'DNA construct for producing proteinaceous materials in eucaryotic cells' [patent_app_type] => B1 [patent_app_number] => 08/484136 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22632 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/455/06455275.pdf [firstpage_image] =>[orig_patent_app_number] => 08484136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3693911 [patent_doc_number] => 05661018 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-26 [patent_title] => 'Cationic phospholipids for transfection' [patent_app_type] => 1 [patent_app_number] => 8/470916 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 8033 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/661/05661018.pdf [firstpage_image] =>[orig_patent_app_number] => 470916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4316864 [patent_doc_number] => 06248516 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-19 [patent_title] => 'Single domain ligands, receptors comprising said ligands methods for their production, and use of said ligands and receptors' [patent_app_type] => 1 [patent_app_number] => 8/470031 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 27 [patent_no_of_words] => 18978 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/248/06248516.pdf [firstpage_image] =>[orig_patent_app_number] => 470031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3722460 [patent_doc_number] => 05681703 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-28 [patent_title] => 'Methods of identifying potentially therapeutically effective agents and cell strains for use therein' [patent_app_type] => 1 [patent_app_number] => 8/471785 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8382 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/681/05681703.pdf [firstpage_image] =>[orig_patent_app_number] => 471785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3693417 [patent_doc_number] => 05660986 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-26 [patent_title] => 'Immortalized human cell lines containing exogenous cytochrome P450 genes' [patent_app_type] => 1 [patent_app_number] => 8/462998 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 9429 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/660/05660986.pdf [firstpage_image] =>[orig_patent_app_number] => 462998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3685558 [patent_doc_number] => 05695940 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Method of sequencing by hybridization of oligonucleotide probes' [patent_app_type] => 1 [patent_app_number] => 8/460853 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 19512 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/695/05695940.pdf [firstpage_image] =>[orig_patent_app_number] => 460853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3619034 [patent_doc_number] => 05614385 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-25 [patent_title] => 'Methods and compositions for high protein production from recombinant DNA' [patent_app_type] => 1 [patent_app_number] => 8/461666 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13312 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 200 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/614/05614385.pdf [firstpage_image] =>[orig_patent_app_number] => 461666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3785470 [patent_doc_number] => 05840574 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Viral vaccines' [patent_app_type] => 1 [patent_app_number] => 8/462591 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 66 [patent_figures_cnt] => 66 [patent_no_of_words] => 8225 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840574.pdf [firstpage_image] =>[orig_patent_app_number] => 462591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4018925 [patent_doc_number] => 05882642 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-16 [patent_title] => 'Genetically engineered transmissible hypovirulence' [patent_app_type] => 1 [patent_app_number] => 8/459065 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 24 [patent_no_of_words] => 11524 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/882/05882642.pdf [firstpage_image] =>[orig_patent_app_number] => 459065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3725888 [patent_doc_number] => 05681932 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-28 [patent_title] => 'Method of using eukaryotic expression vectors comprising the BK virus' [patent_app_type] => 1 [patent_app_number] => 8/458372 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 41972 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/681/05681932.pdf [firstpage_image] =>[orig_patent_app_number] => 458372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3998655 [patent_doc_number] => 05858704 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Method of using eukaryotic expression vectors comprising the BK virus enhancer' [patent_app_type] => 1 [patent_app_number] => 8/459644 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 44 [patent_no_of_words] => 41113 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858704.pdf [firstpage_image] =>[orig_patent_app_number] => 459644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4061985 [patent_doc_number] => 05866405 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Genetically engineered transmissible hypovirulence' [patent_app_type] => 1 [patent_app_number] => 8/459146 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 24 [patent_no_of_words] => 11539 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866405.pdf [firstpage_image] =>[orig_patent_app_number] => 459146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3813877 [patent_doc_number] => 05770397 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-23 [patent_title] => 'Method of using eukaryotic expression vectors comprising the BK virus enhancer' [patent_app_type] => 1 [patent_app_number] => 8/459916 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 41194 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/770/05770397.pdf [firstpage_image] =>[orig_patent_app_number] => 459916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3690048 [patent_doc_number] => 05604099 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-18 [patent_title] => 'Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids' [patent_app_type] => 1 [patent_app_number] => 8/457647 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18286 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/604/05604099.pdf [firstpage_image] =>[orig_patent_app_number] => 457647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3686259 [patent_doc_number] => 05695985 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Thermophilic fungal expression system' [patent_app_type] => 1 [patent_app_number] => 8/456843 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7771 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/695/05695985.pdf [firstpage_image] =>[orig_patent_app_number] => 456843 [rel_patent_id] =>[rel_patent_doc_number] =>)